Biomarin Pharmaceutical and Ascendis Pharma Enter Settlement and License Agreement
BioMarin Pharmaceutical Inc. has entered into a settlement and license agreement with Ascendis Pharma. The agreement is set to take effect on September 24, 2026.
BioMarin Pharmaceutical Inc. has entered into a settlement and license agreement with Ascendis Pharma. The agreement is set to take effect on September 24, 2026.